Newsroom - Page 13

A look at the pharmaceutical industry’s influence and practices, and how patients and providers can support efforts to improve regulation.
On the first day of The Community Oncology Conference: Innovation in Cancer Care, held in Orlando, Florida, April 13-15, 2016, oncologists discussed how their practices are coping with the transition toward quality- and value-based reimbursement.
Many value assessment frameworks are still in their infancy and while the American Society of Clinical Oncology (ASCO)'s framework is still getting input and being adjusted, it has started an important conversation, Stephen Grubbs, MD, vice president for clinical affairs at ASCO, said at the Community Oncology Alliance's 2016 Community Oncology Conference.
What we're reading, April 14, 2016: House passes bill to speed up approval for Zika virus vaccines; spending on prescription brand name drugs grew just 2.8% in 2015; and Maine Senate passes measure to expand Medicaid.
American workers’ compensation payers experienced a 2.2% increase in pharmacy spending in 2015, but effective management programs helped lower injured workers’ drug utilization by 2.6%.
The rise in employee cost-sharing for healthcare predates Obamacare but has taken off since the law passed in 2010. Higher deductibles have been accompanied by stagnant wages, ensuring that the higher payments are deeply felt.
Adverse drug reaction profiles for 12 marketed antidepressant and anticonvulsant medications are inconsistently reported in Europe versus the United States.
The study, funded by Medtronic, follows an earlier study that compared pump users to those using daily injections to manage type 2 diabetes.
Diabetes Compendium
Oncology Compendium
Reimbursement Compendium
HF Compendium